A toxic palmitoylation of Cdc42 enhances NF-κB signaling and drives a severe autoinflammatory syndrome.

Bahia Bekhouche,Aurore Tourville,Yamini Ravichandran,Rachida Tacine,Laurence Abrami,Michael Dussiot, Andrea Khau-Dancasius,Olivia Boccara,Meriem Khirat,Marianne Mangeney,Florent Dingli,Damarys Loew,Batiste Boëda, Pénélope Jordan,Thierry Jo Molina,Nathalia Bellon,Sylvie Fraitag,Smail Hadj-Rabia, Stéphane Blanche,Anne Puel,Sandrine Etienne-Manneville,F Gisou van der Goot,Jacqueline Cherfils,Olivier Hermine,Jean-Laurent Casanova,Christine Bodemer,Asma Smahi,Jérôme Delon

The Journal of allergy and clinical immunology（2020）

引用 31|浏览25

暂无评分

摘要

CDC42 gene mutations arise in large clinical spectra. The de novo R186C variant results in Cdc42 palmitoylation, retention in the Golgi apparatus, and NF-κB hyperactivation, leading to a severe psoriasiform dermatitis, hematological abnormalities and autoinflammation.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要